Robert Rice

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy

Jerry R. Mendell, John T. Kissel, Anthony A. Amato et al. · New England Journal of Medicine · 1995 · 518 citations · Full text

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah et al. · JAMA Oncology · 2021 · 184 citations · Full text

A Targeted Library of Small-Molecule, Tyrosine, and Dual-Specificity Phosphatase Inhibitors Derived from a Rational Core Design and Random Side Chain Variation

Robert Rice, James M. Rusnak, Fumiaki Yokokawa et al. · Biochemistry · 1997 · 84 citations